564 Results (Page 22 of 23)
Egypt Markets Research Reports
Egypt Dental Fluoride Treatment Market Analysis
The Egypt Dental Fluoride Treatment Market was valued at $42.5 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $61.4 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Sigma Pharmaceuticals Industries, Arab Drug Company, MACRO Group, Pharco Pharmaceuticals and Hindustan Unilever Limited among others.
Egypt Financial Assistance Programs Market Analysis
The Egypt Financial Assistance Programs Market was valued at $79.3 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $225.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Roche, Pfizer, Bayer, Merck, GSK, Johnson & Johnson, Novartis among others.
Egypt Periodontal Therapeutics Market Analysis
The Egypt Periodontal Therapeutics Market was valued at $2.4 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $4.4 Mn by 2030. Egypt Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, Prevalence of periodontitis and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Egypt Chronic Cough Therapeutics Market Analysis
Egypt Chronic Cough Therapeutics Market was valued at $18 Mn in 2022 and is estimated to reach $37 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The predominant factor driving the growth of the chronic cough therapeutics market is the prevalent occurrence of persistent coughing associated with chronic respiratory infections. Leading entities in this sector currently include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, Sanofi, Merck & Co., AstraZeneca, Abbott Laboratories, Bayer AG, and Chiesi Farmaceutici.
Egypt Radiology Service Market Analysis
The Egypt Radiology Service Market was valued at $11.2 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $32 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the Egypt Radiology Service Market are Andalusia Al Maadi Hospital, Dar Al Fouad Hospital, As-Salam International Hospital, Andalusia Al Shalalat Hospital, and Arab Contractors Medical Center (ACMC), among others.
Egypt MRI Market Analysis
The Egypt MRI Market was valued at $18.59 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $31.86 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic diseases, improved quality of healthcare services, and emphasis on research and development. The key players in the industry are GE Healthcare, Esaote, Philips Healthcare Egypt, and Fujifilm Healthcare among others.
Egypt Conjunctivitis Therapeutics Market Analysis
The Egypt Conjunctivitis Therapeutics Market was valued at $11 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $20 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, expanding healthcare infrastructure, and the evolving treatment landscape. The industry is primarily dominated by players such as Allergan, Sun Pharma, Novartis, Sirion, Boehringer Ingelheim, Pfizer, and Auven among others.
Egypt Hypersomnia Therapeutics Market Analysis
The Egypt Hypersomnia Therapeutics Market was valued at $14.95 Mn in 2023 and is predicted to grow at a CAGR of 5.73% from 2023 to 2030, to $22.08 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Delta Pharma, Teva, Sedico Pharmaceuticals, and Takeda Pharmaceuticals among others.
Egypt Dental Implant Market Analysis
Egypt Dental Implant Market was valued at $14 Mn in 2023 and is predicted to grow at a CAGR of 11.3% from 2023 to 2030, to $29.60 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, growing dental awareness, and advanced dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Egypt Head and Neck Cancer Therapeutics Market Analysis
The Egypt Head and Neck Cancer Therapeutics Market was valued at $7.93 Mn in 2023 and is predicted to grow at a CAGR of 13.73% from 2023 to 2030, to $19.52 Mn by 2030. The key drivers of this industry include government initiatives, the aging population, and advancements in treatment options. The industry is primarily dominated by players such as Merck, Pfizer, Novartis, and AstraZeneca among others.
Egypt PET Scan Market Analysis
The Egypt PET Scan Market was valued at $5.4 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $8.7 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the Egypt PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
Egypt Compression Therapy Market Analysis
Egypt Compression Therapy Market was valued at $11 Mn in 2022 and is estimated to reach $18 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The increasing incidence of venous disorders, including leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots, is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Mölnlycke Health Care, Sigvaris Group, Medi GmbH & Co., Bauerfeind, BSN Medical, Hartmann Group, Medi-Globe Pharmaceuticals, Aspen Pharmacare, FBNQuest Healthcare, and Juzo.
Egypt Genomic Diagnostics Market Analysis
Egypt Genomic Diagnostics Market was valued at $91.42 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $291.22 Mn by 2030. The key drivers of this industry include Growing Healthcare Expenditure, Advancements in Technology, and Government Initiatives. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Egypt Exosome Research Market Analysis
The Egypt Exosome Research Market was valued at $0.5 Mn in 2023 and is projected to grow at a CAGR of 17.5% from 2023 to 2023, to $1.5 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, Bio-Techne Crop, QIAGEN, Beckam Coulter, Lonza among others.
Egypt Mouth Ulcer Therapeutics Market Analysis
The Egypt Mouth Ulcer Therapeutics Market was valued at $4.3 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $6.2 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as EIPICO, Pharco Pharmaceuticals, Amoun Pharmaceuticals, GlaxoSmithKline PLC, among others.
Egypt Bariatric Surgery Devices Market Analysis
The Egypt Bariatric Surgery Devices Market was valued at $7.5 Mn in 2023 and is projected to grow at a CAGR of 6.7% from 2023 to 2023, to $11.7 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Baxter, Cook Medical, Medtronic, Johnson & Johnson among others.
Egypt CT Scan Market Analysis
Egypt CT Scan Market was valued at $12.91 Mn in 2023 and is predicted to grow at a CAGR of 9.37% from 2023 to 2030, to $24.16 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, increasing healthcare expenditure, an aging population, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Egypt Constipation Therapeutics Market Analysis
Egypt Constipation Therapeutics Market was valued at $51 Mn in 2022 and is estimated to reach $94 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The global growth of the constipation therapeutics market is driven by factors such as aging, sedentary lifestyles, and unhealthy dietary habits. The increasing elderly population, susceptible to chronic conditions, notably contributes to this expansion. Major players in this sector comprise Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck & Co., Novartis, and Pfizer.
Egypt Bio-Implant Market Analysis
The Egypt Bio-implant Market was valued at $182 Mn in 2023 and is predicted to grow at a CAGR of 7.4/% from 2023 to 2030, to $300 Mn by 2030. The Egypt Bio-implant Market is growing due to like Increasing Chronic Disease Prevalence, Rising Disposable Income and Healthcare Spending, and Technological Innovations in Implant Materials. The market is primarily dominated by players such as Alexandria Advanced Technologies, Medica Egypt, Misr Medicare, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Egypt Mental Health Apps Market Analysis
The Egypt Mental Health Apps Market was valued at $17.36 Mn in 2023 and is predicted to grow at a CAGR of 16.7% from 2023 to 2030, to $51.17 Mn by 2030. The key drivers of this industry include government support, rising awareness, and increasing demand. The industry is primarily dominated by players such as Calm, Happify, Headspace, and Safe Space among others.
Egypt Adult Malignant Glioma Therapeutics Market Analysis
The Egypt Adult Glioma Therapeutics Market is valued at around $6 Mn in 2022 and is projected to reach $14 Mn by 2030, exhibiting a CAGR of 10.4% during the forecast period. The Egypt Adult Malignant Glioma Market is driven by factors such as increased advancements in targeted therapies, increased insurance coverage and government support and most importantly, reliance on imported drugs causing low local competitiveness and higher opportunities of growth for newer market players. Key players in the Egypt Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Pharco, Eva Pharma, Siemens, etc. among others
Egypt Herbal Supplements Market Report
The Egypt Herbal Supplements Market was valued at $14.73 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $24.75 Mn by 2030. The key drivers of this industry include rising obesity rates, growing health awareness, and distribution channels. The industry is primarily dominated by players such as Himalaya Wellness, NOW Foods, Botanic Supplements, and Dabur among others.
Egypt Blood Disorder Therapeutics Market
Egypt Blood Disorder Therapeutics Market valued at $38 Mn in 2022, projected to reach $75 Mn by 2030 with a 9% CAGR. The market is fuelled due to a push from a mix of certain factors like the increased prevalence of Blood Disorders in the country, supported by increased awareness and acceptance and availability of treatment options due to recent technological advancements. The Egypt Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Roche, Novartis, Pfizer, AstraZeneca, Sanofi, Grifols, Octapharma, Pharco Pharmaceuticals, EVA Pharmaceuticals etc, among various others.
Egypt Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Egypt Clinical Nutrition for Chronic Kidney Diseases Market was valued at $4.40 Mn in 2023 and is predicted to grow at a CAGR of 7.53% from 2023 to 2030, to $7.30 Mn by 2030. The key drivers of this industry include rising CKD prevalence, a growing geriatric population, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Egypt Dental Endodontics Market Analysis
Egypt Dental Endodontics Market was valued at $4.90 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $7.30 Mn by 2030. The key drivers of this industry include increasing awareness of oral health, the rising prevalence of dental problems, and growing dental infrastructure. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
